From ChatGPT to Treatment: the Future of AI and Large Language Models in Surgical Oncology. Indian J Surg Oncol 2023 Sep;14(3):537-539
Date
10/30/2023Pubmed ID
37900654Pubmed Central ID
PMC10611626DOI
10.1007/s13193-023-01836-3Scopus ID
2-s2.0-85174177337 (requires institutional sign-in at Scopus site) 3 CitationsAbstract
This paper explores the transformative potential of Large Language Models (LLMs) within the context of surgical oncology and outlines the foundational mechanisms behind these models. LLMs, such as GPT-4, have rapidly evolved in terms of scale and capabilities, with profound implications for their applications in healthcare. These models, rooted in the Generative Pretrained Transformer architecture, exhibit advanced natural language understanding and generation skills. Within surgical oncology, LLMs, when integrated into a Generalist Medical AI (GMAI) framework, hold great promise in offering real-time support throughout the cancer journey. However, alongside these opportunities, this paper underscores the importance of ethical, privacy, and efficacy considerations, especially in light of issues like data drift and potential biases. Collaborative efforts among healthcare providers, AI developers, and regulatory bodies are pivotal in ensuring responsible and effective use of LLMs in surgical oncology, thereby contributing to enhanced patient care and safety. As LLMs continue to advance, they are poised to become indispensable tools in the delivery of high-quality, efficient care in this specialized medical field.
